425: Trailblazer Merger I Amends Fees for Cyabra Deal

Trailblazer Merger Corporation I has modified compensation agreements with underwriters and advisors, opting for stock payments and new advisory engagements ahead of its business combination with Cyabra Strategy Ltd.

Summary

• Trailblazer Merger Corporation I (TBMC) is progressing towards its initial business combination with Cyabra Strategy Ltd. (Cyabra), after which it will be renamed Cyabra, Inc.
• Deferred underwriting commissions of $2,070,000, originally agreed to be paid in cash, will now be settled by issuing 207,000 common shares of Trailblazer Holdings, Inc. (PubCo Shares) to the underwriters, valued at $10 per share.
• LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. will each receive 103,500 PubCo Shares for these deferred underwriting commissions.
• LifeSci Capital LLC has waived its previous advisory fee under an agreement dated September 23, 2022.
• LifeSci Capital LLC has entered into a new advisory agreement with Cyabra and Trailblazer Holdings, Inc., under which it will receive 105,000 PubCo Shares as a retainer fee upon the closing of the Business Combination.
• LifeSci Capital LLC will also receive an additional advisory fee of $1,050,000, payable in PubCo Shares 90 days after the closing of the Business Combination, with a minimum conversion price of $4.00 per share.
• Ladenburg Thalmann & Co. Inc. has entered into an advisory agreement with Cyabra and Trailblazer Holdings, Inc., receiving an advisory fee of $1,050,000, payable in PubCo Shares 90 days after the closing of the Business Combination, also with a minimum conversion price of $4.00 per share.
• The escrow agreement's transfer restrictions for the underwriters' shares have been reduced from one year to three months from the closing of the Business Combination.
• All share payments are subject to a 9.99% beneficial ownership limitation for the recipients.

Sentiment

Score: 6

Explanation: The filing outlines necessary financial arrangements for the upcoming business combination, converting cash obligations to equity and securing advisory services. While this preserves cash, it also introduces dilution. The agreements are standard for SPAC transactions, indicating progress towards closing the merger.

Positives

• The conversion of $2,070,000 in deferred underwriting commissions from cash to equity preserves cash for the combined entity, Cyabra, Inc.
• LifeSci Capital LLC waived a previous advisory fee, potentially reducing overall cash outflow for the company.
• New advisory agreements secure ongoing financial and investment banking services from LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc. for the combined entity, supporting strategic planning and capital requirements.
• The reduction of escrow transfer restrictions from one year to three months for underwriters' shares may provide earlier liquidity for those recipients.

Negatives

• The issuance of 207,000 common shares for deferred underwriting commissions and additional shares for advisory fees will result in dilution for existing shareholders.
• The minimum conversion price of $4.00 per share for advisory fees could lead to significant dilution if the stock price is low post-combination.
• The company is incurring new share-based compensation obligations for financial advisory services from LifeSci Capital LLC and Ladenburg Thalmann & Co. Inc.

Risks

• Dilution of existing shareholder value due to the issuance of new common stock for deferred fees and advisory services.
• Potential for stock price volatility to impact the actual value of the share-based compensation received by advisors.
• The 9.99% beneficial ownership limitation could delay the full receipt of shares for advisors if their ownership exceeds this threshold.
• The company is obligated to indemnify financial advisors against losses, except in cases of gross negligence or willful misconduct, which could lead to unforeseen legal expenses.

Future Outlook

The company is actively progressing towards the closing of its initial business combination with Cyabra Strategy Ltd., with new advisory agreements in place to support the combined entity, which will be renamed Cyabra, Inc. The agreements indicate a clear path for compensating key financial partners, primarily through equity, upon the successful completion of the merger.

Management Comments

• Trailblazer Holdings, Inc., to be renamed Cyabra, Inc. after the business combination, has decided to retain LifeSci Capital LLC to provide general financial advisory and investment banking services.
• Trailblazer Holdings, Inc., to be renamed Cyabra, Inc. after the business combination, has decided to retain Ladenburg Thalmann & Co. Inc. to provide general financial advisory and investment banking services.

Industry Context

This filing reflects a common practice in SPAC (Special Purpose Acquisition Company) business combinations where deferred fees and advisory services are often settled through equity to conserve cash for the operating business. The engagement of financial advisors like LifeSci Capital and Ladenburg Thalmann is typical for SPACs navigating complex mergers and seeking post-merger strategic and capital markets support. The shift from cash to equity payments for deferred underwriting commissions is a mechanism to manage liquidity during the transition.

Comparison to Industry Standards

• The conversion of deferred underwriting commissions from cash to equity is a common strategy for SPACs to preserve cash, especially in a challenging market environment where cash is a critical resource.
• The 9.99% beneficial ownership limitation for share recipients is a standard regulatory measure to prevent any single entity from accumulating too much control without additional disclosure requirements.
• The engagement of multiple financial advisors (LifeSci and Ladenburg) for post-combination advisory services is typical for companies seeking broad market exposure and strategic guidance.
• The indemnification provisions for financial advisors are standard in such agreements, protecting advisors from liabilities arising from their services, except in cases of gross negligence or willful misconduct.

Corporate Governance

Stakeholder Impact

• Shareholders: Will experience dilution due to the issuance of new shares for deferred underwriting commissions and advisory fees.
• Underwriters (LifeSci Capital LLC, Ladenburg Thalmann & Co. Inc.): Will receive equity compensation in lieu of cash, and their share transfer restrictions are reduced, potentially allowing earlier liquidity.
• Cyabra Strategy Ltd. (and future Cyabra, Inc.): Benefits from preserved cash and secured financial advisory and investment banking services for strategic planning and capital requirements.

Next Steps

• Closing of the initial business combination with Cyabra Strategy Ltd.
• Effectiveness of the Registration Statement on Form S-1 for the underwriters' shares.
• Effectiveness of the Registration Statement on Form S-4 for LifeSci's retainer shares.
• Payment of advisory fees in PubCo Shares 90 days after the closing of the Business Combination.
• Company to use commercially reasonable efforts to have the S-1 registration statement effective before 90 days from the closing of the Business Combination for Ladenburg's shares.

Key Dates

Recommendation

The filing details necessary, albeit dilutive, financial arrangements for the impending business combination. While the conversion of cash obligations to equity is a positive for cash preservation, the resulting dilution and the ongoing advisory fees represent costs. The agreements are standard for SPACs nearing completion of a de-SPAC transaction. Investors should hold to observe the successful completion of the business combination and the performance of the combined entity, Cyabra, Inc., before making further investment decisions. The immediate impact is neutral to slightly negative due to dilution, but the long-term value depends on the success of the combined business.

Keywords

Trailblazer Merger Corporation I, Cyabra Strategy Ltd., SPAC, Business Combination, Merger, Deferred Underwriting Commissions, Advisory Fees, Equity Compensation, LifeSci Capital LLC, Ladenburg Thalmann & Co. Inc., Dilution, SEC Filing, 8-K, Corporate Governance